Orefice Dominique, Beauvais Catherine, Gossec Laure, Flipon Elisabeth, Fautrel Bruno, Marguerie Laurent, Nataf Henri, Prades Béatrice Pallot, Poilverd Rose Marie, Royant Valérie, Sadji Fatiha, Sordet Christelle, Thevenot Corinne, Rat Anne-Christine
Service de rhumatologie, CHU de Nancy, Hôpitaux de Brabois, allée du Morvan, 54500 Vandoeuvre-lès-Nancy, France.
Service de rhumatologie, Hôpital Saint-Antoine, Hôpitaux universitaires Est Parisien, AP-HP, 75012 Paris, France.
Joint Bone Spine. 2014 Dec;81(6):502-7. doi: 10.1016/j.jbspin.2014.04.010. Epub 2014 Jun 23.
Biodrugs carry specific risks that patients must be aware of and capable of managing. Until now, few studies have addressed the self-care safety skills of patients taking biodrugs. The primary objective of this study was to describe the self-care safety skills of patients taking biodrugs for chronic inflammatory joint disease.
We conducted a nationwide cross-sectional survey. To obtain the most representative sample possible of patients taking biodrugs, we selected rheumatologists at random from the directory of the French Society for Rheumatology (SFR). Each rheumatologist was to include 5 consecutive patients receiving biodrugs. The BioSecure questionnaire was used to collect information on patient self-care safety skills.
Of the 677 included patients, with a mean age of 53 years, 33% were males, 62% had rheumatoid arthritis, and 47% had previously received a therapeutic patient education (TPE) session. The median BioSecure score (percentage of correctly answered items) was 73% (interquartile range, 60-82). The dimensions with the lowest scores were the symptoms requiring a physician visit (median, 75), vaccinations (median, 75), contraception (median, 50), and subcutaneous biodrugs (median, 68). The replies to theoretical items (assessing knowledge) and those to problem-case items (assessing adaptive skills) were discordant.
This study provides concrete data of use for improving the information and TPE of patients taking biodrugs. Skills regarding the symptoms that require a physician visit, vaccinations, contraception, and subcutaneous treatments need to be improved. Interesting information can be obtained by simultaneously testing knowledge and coping.
生物药物具有特定风险，患者必须了解并能够应对。到目前为止，很少有研究涉及使用生物药物患者的自我护理安全技能。本研究的主要目的是描述使用生物药物治疗慢性炎症性关节疾病患者的自我护理安全技能。
我们进行了一项全国性横断面调查。为了获得使用生物药物患者尽可能具有代表性的样本，我们从法国风湿病学会（SFR）名录中随机选择风湿病学家。每位风湿病学家纳入5名连续接受生物药物治疗的患者。使用BioSecure问卷收集患者自我护理安全技能的信息。
在纳入的677例患者中，平均年龄53岁，33%为男性，62%患有类风湿关节炎，47%曾接受过治疗性患者教育（TPE）课程。BioSecure评分中位数（正确回答项目的百分比）为73%（四分位间距，60 - 82）。得分最低的维度是需要就医的症状（中位数，75）、疫苗接种（中位数，75）、避孕（中位数，50）和皮下生物药物（中位数，68）。对理论项目（评估知识）的回答与对问题案例项目（评估适应技能）的回答不一致。
本研究为改善使用生物药物患者的信息和TPE提供了具体有用的数据。需要改善关于需要就医的症状、疫苗接种、避孕和皮下治疗的技能。通过同时测试知识和应对能力可以获得有趣的信息。
